nhlbi | Media Room

Press Release Apr 15, 2021

GRSi Awarded Five Year $96M+ Contract for Infrastructure, Poly/Hybrid-Cloud, DevSecOps, Enterprise Operations, Digital Transformation and Scientific Support to NIH NHLBI

Read Press Release

Press Release Jan 2, 2018

Longevity Biotech Awarded $225K Phase I SBIR Contract From NHLBI/NIH to Develop 5A apoA-I Mimetic Peptide for Treatment of Severe Asthma

Broadens immunomodulatory peptide portfolio while also expanding route of administration capabilities

Read Press Release

Press Release Jan 28, 2014

Vascular BioSciences Awarded $1.2 Million Contract from the NHLBI's VITA Program to Develop CAR Peptide Therapeutic Adjuvant for PAH Targeted Therapy

VBS announced the award of a $1.2 million, milestone-based, 3-year contract from the National Heart Lung Blood Institute (NHLBI) of the National Institutes of Health (NIH) to expedite the development of CAR therapeutic peptide pulmonary hypertension

Read Press Release